Search

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

… Tuesday, May 10, 2016 Summary Memorial Sloan Kettering scientists believe there are many reasons to be hopeful about the future of cancer care and research. Here, we take a look at five promising advances that are transforming the way we think about cancer and delivering new treatment tactics. Highlights

Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data analysis in a press conference at the annual meeting of the American Society of Clinical Oncology. This finding suggests that LS is linked to more types of cancer than previously thought, prompting a call for germline testing for LS in all individuals with MSI-high (MSI-H)/mismatch repair deficient (MMR-D) tumors.

… Saturday, June 2, 2018 Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data analysis in a press conference at the

… Wednesday, August 15, 2018 Summary A woman with an aggressive pituitary tumor responded well to immunotherapy. This successful treatment may lead to a clinical trial testing this approach in more people. Tumors of the pea-size pituitary gland, which sits at the base of the brain and secretes hormones

Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.

… Tuesday, October 5, 2021 Pick up any immunology textbook and you’ll find an explanation of the “innate” and “adaptive” arms of the immune system. The innate arm is active from birth and responds to a predefined set of common threats; the adaptive arm takes time to develop but is more versatile at combatting

The new Fiona and Stanley Druckenmiller Center for Lung Cancer Research brings together MSK physicians and scientists in an intensive, multidisciplinary effort against the number-one cause of death from cancer in the nation.

… Friday, January 8, 2016 Summary Lung cancer causes more deaths in the United States than colon, breast, and prostate cancers combined. The Druckenmiller Center gathers scientists and physicians from across MSK to advance our understanding of the disease, examine novel treatments in preclinical models

Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes.

… Tuesday, March 2, 2021 Surgical resection of symptomatic, benign intradural extramedullary (IDEM) spine tumors provides rapid, significant, and durable improvements in patient-reported outcomes (PROs), according to our study published recently in Neurosurgery .   (1) Historically, these tumors have been

Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.

… Thursday, February 10, 2022 Chris Bourne remembers the moment he knew he wanted to become a researcher. He had just completed freshman year at Swarthmore College in Pennsylvania and landed a summer internship with a pharmaceutical company near where he had grown up in South Brunswick, New Jersey. “I’

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

… Wednesday, October 1, 2008 Summary At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients. As the genetics revolution continues to flourish, discoveries made in the laboratory

A new report says that ovarian cancer research is improving, but more needs to be done, especially with regards to screening at an early stage. Also, where patients receive care makes a big difference in their outcome.

… Friday, March 4, 2016 Summary A new report from the Institutes of Medicine says that ovarian cancer research is improving, but more needs to be done, especially with regards to screening for signs of ovarian cancer  at an early stage. The report also points out that where patients receive care makes

A paper from MSK researchers reports that resistance to sotorasib, a new targeted drug for lung cancer, can be caused by many different molecular changes.

… Thursday, November 11, 2021 The recent accelerated approval of sotorasib (Lumakras TM ) was considered significant because the drug obstructs a cancer-causing protein that for decades scientists thought was “undruggable.” Sotorasib received accelerated approved from the US Food and Drug Administration